News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
The team used CRISPR to inactivate a gene in colon organoids, and found that a specific DNA repair defect underlies a mutational signature in some cancers.
The institute will provide gene editing services and genetically modified cell lines to Analytical Biological Services.
The nonexclusive license allows Arcadia to use the patented technology to develop nutritional and agricultural productivity traits in its core crops.
The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.
The team aims to release the new resource sometime next year, with the hope that it will become as widely used as other institute databases.
Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.